Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Biomed Res Int ; 2019: 2971741, 2019.
Artigo em Inglês | MEDLINE | ID: mdl-30719441

RESUMO

Campylobacter jejuni is one of the most common food-borne bacteria that causes gastrointestinal symptoms. In the present study we have investigated the molecular basis of the anti-Campylobacter effect of peppermint essential oil (PEO), one of the oldest EO used to treat gastrointestinal diseases. Transcriptomic, quantitative reverse transcription-polymerase chain reaction (qRT-PCR) and proteomic, two-dimensional polyacryl amid gel electrophoresis (2D-PAGE) methods have revealed that, in the presence of a sublethal concentration of PEO, the expression of several virulence-associated genes was decreased (cheY 0.84x; flhB 0.79x; flgE 0.205x; cadF 0.08x; wlaB 0.89x; porA 0.25x; cbf2 4.3x) while impaired motility was revealed with a functional analysis. Scanning electron micrographs of the exposed cells showed that, unlike in the presence of other stresses, the originally curved C. jejuni cells straightened upon PEO exposure. Gaining insight into the molecular background of this stress response, we have revealed that in the presence of PEO C. jejuni dominantly exerts a general stress response that elevates the expression of general stress genes like dnaK, groEL, groES (10.41x, 3.63x, and 4.77x). The most important genes dps, sodB, and katA involved in oxidative stress responses showed however moderate transcriptional elevations (1,58x, 1,55x, and 1,85x).


Assuntos
Campylobacter jejuni/efeitos dos fármacos , Mentha piperita/química , Óleos Voláteis/farmacologia , Estresse Oxidativo/efeitos dos fármacos , Óleos de Plantas/farmacologia , Virulência/efeitos dos fármacos , Proteínas de Bactérias/genética , Perfilação da Expressão Gênica/métodos , Regulação Bacteriana da Expressão Gênica/efeitos dos fármacos , Proteômica/métodos , Transcrição Gênica/efeitos dos fármacos , Transcriptoma/efeitos dos fármacos
2.
Acta Biol Hung ; 61(3): 274-81, 2010 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-20724274

RESUMO

The 5alpha-reductase type 1 isozyme is a key enzyme in the metabolism of the androgen steroid hormones and inhibitors of this enzyme represent a new pharmacological treatment for several androgen dependent diseases. We developed a radiosubstrate in vitro incubation method for the determination of 5alpha-reductase type 1 activity using rat liver microsomes as an enzyme source. With this method we have studied the inhibiting activity of novel (5' S)-17beta-(4,5-dihydrooxazol-5-yl)androst-5-en-3-one compounds containing various derivatized phenyl substituents coupled to the exo -heterocyclic moiety. Tests revealed moderate inhibitory actions compared to finasteride, nevertheless, results provide interesting structure-activity relationship data.


Assuntos
3-Oxo-5-alfa-Esteroide 4-Desidrogenase/análise , Inibidores de 5-alfa Redutase , Microssomos Hepáticos/enzimologia , 3-Oxo-5-alfa-Esteroide 4-Desidrogenase/metabolismo , Androstenos/química , Androstenos/farmacologia , Animais , Azasteroides/química , Azasteroides/farmacologia , Inibidores Enzimáticos/química , Inibidores Enzimáticos/farmacologia , Feminino , Finasterida/farmacologia , Técnicas In Vitro , Isoenzimas/análise , Isoenzimas/antagonistas & inibidores , Isoenzimas/metabolismo , Microssomos Hepáticos/efeitos dos fármacos , Oxazóis/química , Oxazóis/farmacologia , Ratos , Relação Estrutura-Atividade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...